As evidence grows, clinicians debate whether diet belongs in specialist clinics or everyday practice — and how nutrition ...

The global nutraceuticals market, valued at approximately USD 416 billion in 2026, is projected to grow at a CAGR of around 9% over the next five years.Key factors driving this growth include ...

“Jay is a proven leader with a strong record of building and scaling science-driven, purpose-led brands,” said Roy Chin, ...

Cashflow is a chief concern for ASX investors. Small caps OMG Group and Clever Culture are repaying the faith after ... Read More The post Cashflow separates winners, as OMG and Clever Culture turn ...

News and commentary from the endocrinology world ...

Alluvial Fund reported a record 41.2% net return for 2025. Read the full Q4 2025 partner letter for detailed portfolio ...

The New York Stock Exchange provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley ...

The key alterations sought are FGFR3 activating mutations or fusions/rearrangements (“susceptible” alterations), for potential use of the FGFR inhibitor erdafitinib (Balversa), and HER2 IHC expression ...

VANCOUVER, BC / ACCESS Newswire / February 3, 2026 / Lobe Sciences Ltd. ("Lobe" or the "Company"), a biopharmaceutical company advancing programs in diseases with unmet medical needs, ...

Shares of CorMedix CRMD have declined sharply over the past month, reflecting investor concerns following its bearish 2026 financial outlook. The guidance points to a more conservative growth ...

PFE beat Q4 estimates, but weak COVID sales and soft 2026 guidance kept shares muted as investors weigh pipeline strength ...

What Pfizer’s recent performance tells you right now Pfizer (PFE) has drawn fresh attention after a period in which the share ...